Annual Accounts Payable
$422.00 K
+$42.00 K+11.05%
31 December 2023
Summary:
Candel Therapeutics annual accounts payable is currently $422.00 thousand, with the most recent change of +$42.00 thousand (+11.05%) on 31 December 2023. During the last 3 years, it has fallen by -$499.00 thousand (-54.18%). CADL annual accounts payable is now -73.46% below its all-time high of $1.59 million, reached on 31 December 2021.CADL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$296.00 K
-$137.00 K-31.64%
30 September 2024
Summary:
Candel Therapeutics quarterly accounts payable is currently $296.00 thousand, with the most recent change of -$137.00 thousand (-31.64%) on 30 September 2024. Over the past year, it has increased by +$46.00 thousand (+18.40%). CADL quarterly accounts payable is now -81.38% below its all-time high of $1.59 million, reached on 31 December 2021.CADL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CADL Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.1% | +18.4% |
| 3 y3 years | -54.2% | -68.0% |
| 5 y5 years | - | - |
CADL Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -73.5% | +11.1% | -81.4% | +18.4% |
| 5 y | 5 years | -73.5% | +93.6% | -81.4% | +18.4% |
| alltime | all time | -73.5% | +93.6% | -81.4% | +18.4% |
Candel Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $296.00 K(-31.6%) |
| June 2024 | - | $433.00 K(-8.3%) |
| Mar 2024 | - | $472.00 K(+11.8%) |
| Dec 2023 | $422.00 K(+11.1%) | $422.00 K(+68.8%) |
| Sept 2023 | - | $250.00 K(-47.9%) |
| June 2023 | - | $480.00 K(-18.9%) |
| Mar 2023 | - | $592.00 K(+55.8%) |
| Dec 2022 | $380.00 K | $380.00 K(-60.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $970.00 K(-38.8%) |
| June 2022 | - | $1.58 M(+14.3%) |
| Mar 2022 | - | $1.39 M(-12.8%) |
| Dec 2021 | $1.59 M(+72.6%) | $1.59 M(+71.9%) |
| Sept 2021 | - | $925.00 K(+21.9%) |
| June 2021 | - | $759.00 K(-49.8%) |
| Mar 2021 | - | $1.51 M(+64.3%) |
| Dec 2020 | $921.00 K(+322.5%) | $921.00 K |
| Dec 2019 | $218.00 K | - |
FAQ
- What is Candel Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Candel Therapeutics?
- What is Candel Therapeutics annual accounts payable year-on-year change?
- What is Candel Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Candel Therapeutics?
- What is Candel Therapeutics quarterly accounts payable year-on-year change?
What is Candel Therapeutics annual accounts payable?
The current annual accounts payable of CADL is $422.00 K
What is the all time high annual accounts payable for Candel Therapeutics?
Candel Therapeutics all-time high annual accounts payable is $1.59 M
What is Candel Therapeutics annual accounts payable year-on-year change?
Over the past year, CADL annual accounts payable has changed by +$42.00 K (+11.05%)
What is Candel Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CADL is $296.00 K
What is the all time high quarterly accounts payable for Candel Therapeutics?
Candel Therapeutics all-time high quarterly accounts payable is $1.59 M
What is Candel Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CADL quarterly accounts payable has changed by +$46.00 K (+18.40%)